Express News | Shattuck Labs Inc : Citigroup Cuts Target Price to $10 From $11

Breakings04:59

HC Wainwright & Co. : The Shattuck Labs (STTK.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $28.00.

HC Wainwright & Co. : The Shattuck Labs (STTK.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $28.00.

Zhitong FinanceMay 15 10:50

TD Cowen Remains a Buy on Shattuck Labs (STTK)

TipRanksMay 15 06:16

Promising Clinical Trial Results Support a Buy Rating for Shattuck Labs

TipRanksMay 15 05:09

Shattuck Labs to Present Additional Data From the Phase 1B Dose Expansion Clinical Trial of SL-172154 With Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 Mutant (TP53m) Acute Myeloid Leukemia (AML) Patients

Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK) today announced the presentation of additional data from the Phase 1B dose expansion clinical trial of SL-172154 with AZA in frontline HR-MDS and TP53m AML patients.

GlobeNewswireMay 14 15:15

Buy Rating Affirmed: Shattuck Labs' Promising Clinical Developments in HR-MDS and AML Treatment

TipRanksMay 14 11:15